1
|
Mannucci PM, Makris M. Managing prostatic illness in persons with haemophilia. Haemophilia 2022; 28:369-370. [PMID: 35213757 DOI: 10.1111/hae.14519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2022] [Revised: 02/08/2022] [Accepted: 02/09/2022] [Indexed: 11/26/2022]
Affiliation(s)
- Pier Mannuccio Mannucci
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy
| | - Michael Makris
- Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK
| |
Collapse
|
2
|
Gautier P, Guillet B, Sigaud M, Claeyssens S, Volot FG, Chamouni P, Lienahrt A, Frotscher B, Fournel A, Castet S, Poumayou C, Gay V, Thuret R, Wibaut B, Biron-Andreani C. Prostate biopsy and prostate cancer management in patients with haemophilia: The experience of French Haemophilia Treatment Centres. Haemophilia 2022; 28:437-444. [PMID: 35201650 DOI: 10.1111/hae.14507] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2021] [Revised: 01/18/2022] [Accepted: 01/26/2022] [Indexed: 12/12/2022]
Abstract
BACKGROUND Data are limited on prostate cancer (PC) management in patients with haemophilia (PWH). AIM To describe PC screening and diagnosis, treatment modalities and bleeding complications in a group of unselected PWH followed at French Haemophilia Treatment Centres (HTCs) PATIENTS AND METHODS: PC screening, management and bleeding complications were retrospectively investigated at 14 French HTCs between 2003 and 2018. RESULTS Among> 1549 > 50-year-old PWHs, 73 (4.7%) underwent PC screening (median age 71.1 years; 67/6 HA/HB, 17/56 severe-moderate/mild). At diagnosis, haematuria was infrequent. Prophylaxis was administered during 76/86 (88%) prostate biopsies (PB) (n = 67 clotting factor concentrates, CFC; n = 9 desmopressin; n = 17 associated with tranexamic acid, TA). Bleeding (11/86, 12.8%) occurred mainly post-prophylaxis (median delay: 7 days): haematuria (9/11, 81.8%), and rectal bleeding (2/11, 18.2%) including one major (1.2%). PC was confirmed in 50/86 PB and in two prostatectomy specimens (total n = 50 patients, n = 6 with only active surveillance). Surgery (n = 28/44 patients) was managed with CFC. Fifteen patients had radiotherapy/brachytherapy, 10 had hormone therapy; CFC-based prophylaxis was only prescribed for brachytherapy (n = 2). Major bleedings occurred in 3/28 (10.7%) and 2/15 (13.3%) patients who underwent surgery and radio/brachytherapy, respectively. No bleeding risk factor was found. CONCLUSION Our data indicate that PB requires prophylaxis for atleast 7 days, using CFC, desmopressin or TA in function of haemophilia severity. PC surgery should be considered at high bleeding risk. Long-term post-procedural CFC or oral TA could be discussed. Radiotherapy/brachytherapy also should be managed with prophylaxis (CFC or TA).
Collapse
Affiliation(s)
- Philippe Gautier
- Haemophilia Treatment Centre, Associated National Reference Willebrand Centre, University hospital, Caen, France
| | - Benoit Guillet
- Haemophilia Treatment Centre, University hospital, Rennes, France
| | - Marianne Sigaud
- Associated National Reference Haemophilia Treatment Centre, University hospital, Nantes, France
| | | | | | - Pierre Chamouni
- Haemophilia Treatment Centre, University hospital, Rouen, France
| | - Anne Lienahrt
- Reference Haemophilia Treatment Centre, University hospital, Lyon, France
| | - Birgit Frotscher
- Haemophilia Treatment Centre, University hospital, Nancy, France
| | | | - Sabine Castet
- Haemophilia Treatment Centre, University hospital, Bordeaux, France
| | - Catherine Poumayou
- Haemophilia Treatment Centre, La Timone Hospital APHM, Aix Marseille University, Marseille, France
| | - Valérie Gay
- hospital, Haemophilia Treatment Centre, Chambery, France
| | - Rodolphe Thuret
- Department of urologic surgery, University hospital, Montpellier, France
| | - Bénédicte Wibaut
- Haemophilia Treatment Centre, National Reference Willebrand Centre, University hospital, Lille, France
| | | |
Collapse
|
3
|
Mesnard B, Drillaud N, Sigaud M, Hakim G, Chelly S, Ternisien C, Fouassier M, Chelghaf I, De Vergie S, Perrouin Verbe MA, Rigaud J, David A, Trossaërt M, Branchereau J. Prostate interventions in patients with mild haemophilia: Safe and feasible. Haemophilia 2021; 27:e659-e666. [PMID: 34342928 DOI: 10.1111/hae.14388] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2021] [Revised: 07/15/2021] [Accepted: 07/16/2021] [Indexed: 11/29/2022]
Abstract
INTRODUCTION To date, there is no specific recommendation or evaluation of the morbidity of prostate surgery in patients with haemophilia (PWH) although this surgery is common and at high risk of bleeding. AIM To assess the post-operative morbidity of benign prostate hyperplasia (BPH) surgeries and of oncological prostate interventions in patients with mild haemophilia A or B. METHODS We performed a monocentre, epidemiological, in real life study. Data were collected between 1 January, 1997 and 1 September, 2020 and focused on prostate biopsy, radical prostatectomy, prostate radiotherapy, simple prostatectomy, transurethral resection of prostate (TURP) and laser-vaporisation in patients with mild haemophilia A or B. RESULTS Between 1 January, 1997 and 1 September, 2020, 51 interventions were performed on 30 patients with mild haemophilia. Haemophilia A represented 93.33% of the population and haemophilia B 6.67%. For prostate biopsies (n = 24), median length of hospitalisation was 4 days and only one patient needed a blood transfusion. No patient needed re-admission. For prostatectomy (n = 10), one patient presented with intra-operative and post-operative bleeding. Two patients required re-admission. The other patients did not present any significant haemorrhagic symptoms. For radiotherapy (n = 4), two patients presented a grade II complication (radiocystitis and radiorectitis). For BPH surgeries, during hospitalisation, laser-vaporisation (n = 5) was less haemorrhagic than TURP (n = 5) but after hospital discharge, 60% of patients presented a haemorrhagic complication with two readmissions and one surgical re-explorations. CONCLUSION Performed in a specialised centre, prostate surgeries and interventions in patients with mild haemophilia is feasible with acceptable morbidity.
Collapse
Affiliation(s)
- Benoit Mesnard
- Department of Urology and Transplantation Surgery, Nantes University Hospital, Nantes, France
| | | | - Marianne Sigaud
- Haemophilia Centre, Nantes University Hospital, Nantes, France
| | - Gabriella Hakim
- Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK
| | - Samuel Chelly
- Department of Urology, Angers University Hospital, Angers, France
| | | | - Marc Fouassier
- Haemophilia Centre, Nantes University Hospital, Nantes, France
| | - Ismaël Chelghaf
- Department of Urology and Transplantation Surgery, Nantes University Hospital, Nantes, France
| | - Stéphane De Vergie
- Department of Urology and Transplantation Surgery, Nantes University Hospital, Nantes, France
| | | | - Jérôme Rigaud
- Department of Urology and Transplantation Surgery, Nantes University Hospital, Nantes, France
| | - Arthur David
- Department of Radiology, Nantes University Hospital, Nantes, France
| | - Marc Trossaërt
- Haemophilia Centre, Nantes University Hospital, Nantes, France
| | - Julien Branchereau
- Department of Urology and Transplantation Surgery, Nantes University Hospital, Nantes, France.,Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.,Centre de Recherche en Transplantation et Immunologie CRTI Inserm, Nantes University, Nantes, France
| |
Collapse
|
4
|
Miesbach W, Reitter-Pfoertner SE, Klamroth R, Langer F, Wolf HH, Tiede A, Siegmund B, Scholz U, Müller PR, Eichler H, Pabinger I. Co-morbidities and bleeding in elderly patients with haemophilia-A survey of the German, Austrian and Swiss Society of Thrombosis and Haemostasis Research (GTH). Haemophilia 2017. [DOI: 10.1111/hae.13296] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Affiliation(s)
- W. Miesbach
- Medical Clinic II; Institute of Transfusion Medicine; Goethe University; Frankfurt Germany
| | - S.-E. Reitter-Pfoertner
- Division of Haematology and Haemostaseology; Department of Medicine I; Medical University; Vienna Austria
| | - R. Klamroth
- Department of Angiology and Haemostaseology; Vivantes Clinic; Berlin Germany
| | - F. Langer
- II. Medical Clinic; University Clinic Eppendorf; Hamburg Germany
| | | | - A. Tiede
- Hannover Medical School; Hannover Germany
| | - B. Siegmund
- Institute for Thrombophilia and Haemaostaseology; Münster Germany
| | - U. Scholz
- Center of Haemostasis; MVZ Labor Leipzig; Germany
| | | | - H. Eichler
- Institute of Haemostaseology and Transfusion Medicine; University Hospital; Homburg/Saar Germany
| | - I. Pabinger
- Division of Haematology and Haemostaseology; Department of Medicine I; Medical University; Vienna Austria
| |
Collapse
|
5
|
Biron-Andreani C, de Moerloose P, D'oiron R, Chambost H, Schved JF, Hermans C. Cancer detection and management in patients with haemophilia: a retrospective European multicentre study. Haemophilia 2013; 20:78-82. [DOI: 10.1111/hae.12250] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/10/2013] [Indexed: 12/29/2022]
Affiliation(s)
- C. Biron-Andreani
- Haemophilia Treatment Centre; Saint-Eloi University Hospital Montpellier; Montpellier France
| | - P. de Moerloose
- Haemophilia Treatment Centre; University Hospital and Faculty of Medicine; Geneva Switzerland
| | - R. D'oiron
- Haemophilia Treatment Centre; Paris-Le Kremlin Bicêtre; Bicêtre APHP University Hospital; Le Kremlin Bicêtre France
| | - H. Chambost
- Haemophilia Treatment Centre; La Timone Hospital APHM; Aix Marseille University; Marseille France
| | - J.-F. Schved
- Haemophilia Treatment Centre; Saint-Eloi University Hospital Montpellier; Montpellier France
| | - C. Hermans
- Haemophilia Treatment Centre; St-Luc University Hospital Brussels; Brussels Belgium
| |
Collapse
|